Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke

Abstract

This study, conducted at multiple institutions throughout the United States, suggests that favorable clinical outcomes and low rates of symptomatic intracerebral hemorrhage can be achieved using tPA for stroke treatment.